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PREFACE 
Knowledge of organ functions under physiological and pathological 
conditions is a prerequisite for progress in surgery. Surgery today 
implies a wide range of processes. Preoperative investigations 
intended to reveal aetiological factors and concomitant interrelated 
diseases constitute an important part of the surgeons"task. 
Several complex factors contribute to the formation of choleste­
rol gall stones. These factors are only partly mapped out and moreover 
our knowledge of the basic physiological mechanisms involved in bile 
flow and biliary lipid secretion in man is limited. Findings from 
experiments in animals are not always directly transferable to man. 
Hence, studies in man are necessary to clearify these basic mechanisms 
and such studies call for access to the biliary tree, which can only 
be achieved in patients undergoing bile duct surgery. 
The present work is an attempt to evaluate some physiological 
and pathophysiological mechanisms concerning bile flow and biliary 
lipid secretion in man. 
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INTRODUCTION 
The incidence of gall stones in different populations varies widely, 
from a low of 1.35 % in Kampala, Uganda, to a high of 73 % in 
American female Pima indians (cf 28). Direct comparisons between 
reported incidence figures are difficult to make because of factors 
such as divergent grouping of patients and varying completeness of 
the study material. In an autopsy study in Malmö and Prague of all 
deaths during the years 1963 - 1966 the prevalence of gall stones 
was similar in the two cities: 29-32 % in males and 52 I in females 
in the age group 40-99 years (91). 
The predominating type of gall stone differs in different parts 
of the world (81). In western Europe and the USA cholesterol gall 
stones are most common, constituting from 73 % (85) to 90 % (68) of 
all stones. Cholesterol gall stones and pigment gall stones probably 
represent at least two quite different pathological conditions (85). 
Although most gall stones probably remain undetected because they 
are asymptomatic (28), gall stone disease constitutes an important 
economic burden for the community and gives rise to much individual 
suffering. In Sweden around 27.000 cholecystectomies were performed 
in 1974. Cholecystectomies constituted 11 % of all operations 
performed that year. The total duration of stay in hospital for these 
operations amounted to 207.000 days, representing a cost of about 
100 milj. Swedish Crowns per year. The mean period of stay in hospital 
for uncomplicated cholecystectomy was 7.9 days. The mean period of 
stay in hospital for patients with chronic cholecystitis, acute 
cholecystitis and bile duct gall stones was 9.4, 11.7 and 15.7 days, 
respectively (Scherstén, personal report). 
Among possible factors determining the prevalence of gall stones 
that have been discussed are sex, age, social class and body weight 
(28, 85, 91). Associations between gall-stone formation and certain 
diseases have also been reported e.g. Crohn's disease of the terminal 
ileum (29) and diabetes (28). 
Spontaneous occurrence of gall stones has been reported in many 
species apart from man (47). Spontaneous cholesterol gall-stone 
formation in baboons has been used as an experimental model (35). 
Cholesterol gall-stone formation can be induced in several species, 
for example in the hamster, prairie dog and Rhesus monkey. Results 
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obtained from these experimental animal models cannot, however, be 
directly transferred to man. 
It has been clearly established that excess of cholesterol in 
relation to bile acids and phospholipids in bile is the main physico-
chemical prerequisite for cholesterol gall-stone formation (3, 65, 
66, 74, 75). The biliary lipids form mixed micelles in water with a 
cholesterol-holding capacity depending mainly on the relative 
concentrations of bile acids and lecithin. Variation in the amount of 
solids in bile is of little significance within the range of concen­
trations existing in human bile (3). The micellar cholesterol-holding 
capacity is also dependent on the type of bile acid that is taking 
part in the micelle formation. The fatty acid pattern of lecithin may 
also play a role for the cholesterol-holding capacity even though 
this has not been convincingly shown (31, 50, 62). 
The limit for biliary micellar cholesterol saturation has been 
estimated by Admirand & Small (3) and by others (30, 33, 45). Bile 
supersaturated with cholesterol is not always associated with stone 
formation, as demonstrated by the finding that cholesterol-super­
saturated bile is frequent in healthy humans (33). This may partly 
be explained by the fact that cholesterol can be held in a metastable 
solution for some time at concentrations above the micellar concentra­
tion (32). Hence, the time bile remains in the gall bladder or the 
bile ducts may be of great importance. This time can probably be 
increased because of disturbances in the gall bladder emptying func­
tion, during pregnancy (54), after gastric surgery (41) and because of 
stasis in the bile ducts. Presence of nucleating substances as 
desquamated cells, bacteria, mucus substances, calcium salts and 
pigments in the gall bladder has also been discussed (34, 75). 
Although many factors may interact in the formation of chole­
sterol gall stones, the secretion of bile supersaturated with chole­
sterol seems to be a prerequisite and a common phenomenon (3, 65, 66). 
Because of this supersaturated bile has been designated "lithogenic 
bile" (cf 65). 
Theoretically, bile can be converted from being unsaturated with 
cholesterol to being saturated in the gall bladder. This conversion 
might occur because of deconjugation of bile acids (88), because of 
bile acid absorption (56) or because of lecithin deacylation or ab­
sorption (73). However, in the normal gall bladder the degree of 
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Saturation is rather slightly decreased. The reason for this 
phenomenon is that bile acids are absorbed to a very slight extent. 
Intact lecithin is appreciably absorbed (49) but the absorption of 
cholesterol is higher (48). It has been shown repeatedly that bile 
supersaturated with cholesterol can be secreted from the liver (51, 
67) and at present it is generally accepted that this is the main 
reason for the occurrence of "saturated" bile (26, 65, 75, 76, 79, 86, 
87). 
It is now generally accepted that the biliary bile acid secretion 
rate determines the biliary bile flow, lecithin secretion rate and to 
some extent also the cholesterol secretion rate. It has been shown in 
man (51, 67), and later in several animal species, that the degree of 
cholesterol saturation of hepatic bile is inversely related to the 
bile acid secretion rate (17, 27, 77, 89). Factors influencing the 
biliary bile acid secretion rate may thus determine the "saturation" 
of hepatic bile. Thureborn showed that interruption of the entero-
hepatic circulation (EHC) of bile acids in man caused a pronounced 
reduction of the bile acid to cholesterol ratio and the phospholipid 
to cholesterol ratio in hepatic bile (84). Moreover, bile acids 
returning to the liver via the EHC exert a negative feedback effect 
on bile acid synthesis, which was first shown in the rat (7) and 
later confirmed in man (25, 40, 82). It has been suggested that this 
inhibitory effect is located at the 7-fX-hydroxylation of cholesterol 
(70). The hepatic synthesis rate of cholesterol - the precursor for 
bile acid synthesis - is also influenced by the circulating bile acid 
pool (70). In addition, bile acids are known to stimulate hepatic 
lecithin synthesis inman (10, 53) and in the rat (4). 
The amount of bile acids returning to the liver via the EHC thus 
influences the degree of cholesterol saturation in hepatic bile. The 
size of the bile acid pool and the rate of bile acid pool circulation 
are of importance. Both the size of the pool and its rate of circular 
tion may be influenced by other factors primarily acting on gall bladder 
function. Among these factors are sex hormones (54), gastrointestinal 
hormones and gall bladder innervation (41), and eating habits and diet, 
which can influence the degree and frequency of gall bladder emptying. 
It has been shown that the hepatic bile in gall stone patients with 
nonfunctioning gall bladder is less saturated with cholesterol than 
that of gall stone patients with functioning gall bladder (11). 
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The enterohepatic circulation of bile acids may also be influen­
ced in the intestine, i.e. by non-nutritive fibres (37) and ileal 
dysfunction (16). 
The regulation of cholesterol and bile acid synthesis may be 
disturbed, as in dyslipoproteinaemia (36). Moreover, it has been 
reported that gall stone patients have a higher liver cholesterol 
concentration, higher 3-hydroxy-3-methylglutaryl-CoA reductase 
activity (HMG-CoA reductase activity) and lower cholesterol 7 -<7C-
hydroxylase activity as compared with normal controls (61). These 
findings suggest that gall stone disease is a disease of liver meta­
bolism. 
The aims of the present investigation were: 
1. to study the role of bile acids for bile flow in man, 
2. to study the role of bile acids for biliary lipid secretion and 
to evaluate the role of bile acids for hepatic lecithin synthesis 
in man, and 
3. to evaluate the importance of hepatic secretion of cholic acid 
(CA) and chenodeoxycholic acid (CDCA) for the degree of biliary 
cholesterol saturation. 
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PATIENTS 
Details of the patients included in the study are listed in table I. 
All the patients taking part in the experiments were thoroughly 
informed about the details and the aims of the study. Participation 
in the study was voluntary and the patients were told that they were 
free to stop the experiment at any time. No complications of the 
experiments were observed. 
METHODOLOGICAL CONSIDERATIONS 
Experimental procedures 
The time of the experiment (I, III, IV), 7-12 days postoperatively, 
was chosen because the liver function, bile flow and biliary lipid 
composition are considered to be restituted and stabilized about 7 
days after operation (44, 57, 63, 84). The EHC was kept intact until 
the experiments were performed and the patients were mobilized and had 
an ordinary hospital diet. They were fasted for 12 hours before the 
start of the experiment. In ten patients (I) the EHC was kept intact 
during the study. In these patients bile samples were taken amounting 
altogether to not more than SO ml of bile, which means that less than 
10 I of the bile was diverted (51). A diversion of bile of this 
magnitude does not influence the secretion of biliary lipids (17). 
The catheterization technique (I, II, III, IV) in the experiments 
with interrupted EHC has previously been reported in detail (51). 
Instead of the t-tube previously used, a babyfeeding-tube (size 8) 
was inserted in a proximal direction into the common hepatic duct 
through the cystic duct. It might be questioned whether such a 
catheter is of sufficient diameter not to influence the bile flow. 
Since the relationship between the bile acid secretion rate and bile 
flow was linear throughout the measured range of bile flow rates in all 
the experiments, it seems unlikely that the catheter limited the flow. 
The position of the catheters in the bile duct was checked by contrast 
X-ray examination in all cases. When the balloon catheter was inflated 
with saline (o.7 - 1.0 ml) the patients described slight discomfort 
of short duration. During the experiment small amounts of colourless 
fluid were obtained from the balloon catheter, which had its tip open 
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distally to the balloon, indicating that the balloon effectively 
prevented bile from passing the balloon. 
Duodenal administration of cholic or chenodeoxycholic acid (III, 
IV) might cause release of gastrointestinal hormones such as secretin. 
A release of gastrointestinal hormones would be expected to enhance 
the ductular bile flow (9) during bile acid administration but this 
was not observed. 
In the ^C-mannitol experiments (III) the ^C-mannitol clearance 
B (Cm) was calculated according to the formula: Cm = F . _m (F = bile 
^m 
flow; Bm = DPM in bile; Pm = DPM in plasma). The biliary clearance of 
mannitol and erythritol has been used as a measure of the canalicular 
bile flow in different species (9, 20, 21, 57, 90). The method is 
based on the fact that the hepatocytes are permeable to inert carbo­
hydrates and on the assumption that they are excreted through the bile 
ducts without passing the ductular membranes (64). Mannitol was chosen 
as a marker instead of erythritol on the basis of reports from studies 
in dogs indicating that erythritol, in contrast to mannitol, enters 
the bile at the secretin responsive area (5). 
14 C-mannitol in saline was administered intravenously at a 
constant infusion rate. Thereby, the blood concentration of C^-
-mannitol was kept fairly constant, without rapid changes, throughout 
the experiments. This means that the passage time for the ^C-mannitol 
molecule from the canaliculi to the extrahepatic bile ducts can be 
neglected when the clearance is calculated. The liver biopsy technique 
(V) has previously been described in detail (8). The liver biopsies 
were taken immediately after opening of the abdominal cavity and the 
piece of liver was placed in ice-chilled Krebs Ringer Phosphate (KRP) 
buffer, pH 7.4, and immediately transported to the laboratory for 
further processing (< 5 min). The conditions for determination of 
lipid synthesis in liver slices have been described previously (52). 
Analytical procedures 
Bile acids in bile (I, II, III, IV) were extracted according to the 
method of Schoenfield et al. (69) and the bile acids were quantitated 
and separated as described previously (51). Lipid extraction and 
quantification were performed as described previously (6, 23, 24, 78, 
8 0 ) .  
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Radioactivity was determined in a Packard Tri-Carb (3320) liquid 
scintillation spectrometer. Correction for quenching was performed by 
the external standard method. The incorporation of choline and methyl-
methionine into lecithin (V) can be regarded as a special application 
of a known technique (52). 
Statistics 
(I, II) Analysis of variance was performed to test the variations in 
individual biliary lipid concentrations. Bivariate regression was 
calculated according to the method of least squares. Student's T-test 
was applied to test differences between groups. 
(III) Linear regressions were calculated according to the method of 
least squares. Differences between regression coefficients and inter­
cepts were tested by analysis of variance. 
(IV) The Mann-Whitney U-test was used to test differences between 
groups (71). Differences between regression coefficients and inter-
cepts were tested by analysis of variance. Experimental data were 
tested for best fit to eight equations: y = a + bx; y = a + bx + 
cx^; y = a + bx + cx^ + dx"^; y = Ae^x; y = Ax^; y = Ax^ecx; y = a + 
b/x; y = x/(a + bx). Curvilinear multiple regression analysis was 
performed as described by Draper & Smith (19). 
(V) The T-test was applied to test differences between groups. To test 
the difference between two small groups the Wald-Wolfowitz nonpara-
metric test was applied (71). 
The choice between parametric and nonparametric tests has in 
all cases been based on the size of the groups compared. In papers 
Iil-V calculations have been performed by means of a programmable 
computer (Olivetti P652). 
13 
RESULTS AND DISCUSSION 
1. Bile acids and bile flow (11,111") 
During depletion of the bile acid pool (secretion of mixed bile acids) 
as well as during CA administration (secretion of mainly CA; 
73 + 3 % (SEM)) and CDCA administration (secretion of mainly CDCA; 
88 + 2 % (SEM)) the relationships between the bile acid secretion 
rate and bile flow and bile acid secretion rate and biliary mannitol 
clearance were of the same linear type (III).The regression coeffi­
cients in these relationships were not significantly different from 
each other, indicating that CA, CDCA or a mixture of CA, CDCA and 
deoxycholic acid promoted the same bile flow per umol of bile acid 
( sy 0.011 ml . umol ). The calculated bile acid independent canali­
cular flow ( -»0.17 ml . min ^ ) and the ductular flow (^ü0.08 ml . 
min ^ ) did not differ significantly between the three different 
experimental conditions. The interindividual variations were small. 
The calculated bile acid independent flow (^0.025 ml . min ) and 
bile acid dependence are in striking agreement with the previous 
findings of Scherstén et al (67) who reported a bile acid independent 
flow of 0.20 ml . min ^  and bile acid dependency of bile flow of 
0.014 ml . umol ^ bile acid. 
Hie average bile flow at intact EHC in this study was 0.43 ml . 
min which is in good agreement with previous reports of 24 h bile 
secretion of 500 - 600 ml in cholecystectomized patients (44, 84). At 
this bile flow the calculated ductular contribution is 20 % and 
canalicular contribution 80 %, half of which is bile-acid independent. 
All patients in the study had a normal biliary tree as judged from 
peroperative cholangiograms and it seems likely that the canalicular 
and ductular contributions to bile flow are of the same magnitude even 
in normal subjects (Fig. 1). 
Boyer and Bloomer and Prandy et al (9, 57) have reported corre­
sponding values of canalicular and ductular bile flow in man. The 
small discrepancies between their figures and ours can be ascribed 
to differences in methods and the patients studied. 
In the postcholestatic patients (II) statistically significant 
linear relationships between the bile acid secretion rate and bile 
flow were obtained in four patients, indicating that bile acids 
determine bile flow even at the low bile acid secretion rates obtained 
14 
, Vlyvt/tArt 
CANALICULAR FLOW 
BILE ACID DEPENDENT FLOW (40%) 
BILE ACID INDEPENDENT FLOW (40%) 
DUCTULAR FLOW 
(SECRETIN STIMULATED) 
(20%) 
Fig. 1: Relative contributions to hepatic bile flow from canalicular 
bile-acid-dependent and independent flow and from ductular flow 
during intact enterohepatic circulation of bile acids. 
in these patients. Great interindividual variations in bile acid 
dependency and calculated bile acid independent flow were registered. 
These variations may partly be ascribed to interindividual differences 
in the width of the bile ducts (58). 
2. Bile acids and biliary secretion of lipids 
A._Biliary_bile acids _£IX IV)_ 
During duodenal administration of CA or CDCA to patients with depleted 
bile acid pool (IV) the biliary bile acid secretion rate increased. 
After 4 h of CA administration this acid constituted 69 + 5 % (SEM) 
of the total bile acids in bile. The corresponding value for CDCA in 
the CDCA experiments was 87 + 2 % (SEM). Both during CA and CDCA 
infusion the glycine to taurine ratio increased from 4.5 + 0.6 (SEM) 
to 15.6 + 2.9 (SEM). This increase can be explained by the greater 
hepatic availability of glycine as compared to taurine (cf 22). 
It has been suggested that the inhibitory effect of bile acids 
returning to the liver via EHC on the biliary bile acid synthesis is 
different for CA and CDCA, owing to different effects on the rate-
-limiting step in bile acid synthesis (cholesterol-7-oc-hydroxylase) 
(70). This difference in inhibitory effect has, however, not been 
found by Danielsson (14). The reason for this discrepancy may be due 
to differences in methodology and to diurnal variations (13). The 
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biliary bile acid concentration did not show statistically significant 
diurnal variations in the ten gall stone patients studied (I). During 
bile acid pool depletion (IV) there was a statistically significant 
decrease in the serum bile acid concentration in systemic blood. 
During administration of CA or CDCA there was a statistically signi­
ficant increment in the serum bile acid concentrations in systemic 
blood. This increase was more pronounced in the CDCA experiments than 
in the CA experiments (Table II). The mean biliary bile acid secretion 
rate was slightly higher in the CDCA experiments (11.9 + 0.9 (SEM) 
umol . min 1) as compared with the CA experiments (8.8 + 0.8 (SEM) 
umol . min ^ ) (P<0.01). Factors influencing the intestinal and 
hepatic uptake of bile acids are probably the main determinants for 
these variations. In a current study we found diurnal variations in 
serum bile acid concentrations in portal and systemic blood in five 
patients supporting this hypothesis (39). In these patients the 
pattern of variation was similar in portal and systemic blood with 
postprandial elevations (Fig. 2). 
30 
20 
0 
8 am 9am noon 1pm 4pm 5pm 8pm 12pm 5am 
Light Heavy Heavy Light 
Meal Meal Meal Meal 
Fig. 2: Mean values of bile acid concentrations in systemic ( y ) 
and portal (|| ) serum in five patients - diurnal variation. 
B. Biliary lecithin (I, II, IV, V) 
A curvilinear relationship between bile acid and lecithin secretion 
rates with the best fit to a parabolic function was obtained in the 
three experimental situations - depletion of the bile acid pool 
(r = 0.91), CA infusion (r = 0.95) and CDCA infusion (r = 0.85)(IV). 
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The y-intercept at extrapolation to zero bile acid secretion rate 
was not statistically significantly different from zero, indicating 
that lecithin is not secreted without bile acids. In the postchole-
static situation (II) the relationship between the bile acid secretion 
rate and the lecithin secretion rate showed the best fit to a linear 
function (r = 0.74). This discrepancy may be explained by the smaller 
range of bile acid secretion rates in these patients. The present 
data confirm previous reports of the role of bile acids in determining 
lecithin secretion (51, 67) and this role seems to be valid even in 
the postcholestatic situation. Furthermore, the mean lecithin secre­
tion rate per umol of bile acids was statistically significantly 
higher during CA secretion (0.45 + 0.03 (SEM) umol lecithin . umol 
bile acids ^) than during CDCA secretion (0.30 + 0.03 (SEM) umol 
lecithin . umol bile acids-1) (F = 13.7, P< 0.01). It has been shown 
that bile acids exert a stimulatory effect on hepatic lecithin 
synthesis (4, 10) and that bile acids returning to the liver influence 
the synthesis of biliary lecithin (53). Evidence has been presented 
that biliary lecithins are mainly derived from the CDP choline 
(CytidineDiPhosphate) synthesis pathway (2). In view of these results 
a stimulatory effect of bile acids on the incorporation of choline 
into lecithin would have been expected. In the present study we did 
not find any effect of bile acids on the in-vitro rate of incorpora­
tion of choline into hepatic lecithins (V). Nor did we find an effect 
of bile acids (CA or CDCA) on the rate of incorporation of methyl-
-methionine into lecithins. The reason for their lack of stimulation 
is not known. One possibility is that the bile acids might exert their 
stimulation on earlier steps in the synthesis pathway. Whatever the 
reason may be, the different effects of CA as compared to CDCA on 
biliary lecithin secretion rate cannot be explained by the present 
results. 
C. _Bi 1 iary_cholestero1_ ( I_, _I_I » _IV) 
The secretory association between bile acid secretion and cholesterol 
secretion could be demonstrated during bile acid pool depletion and 
during cholic acid administration (IV). The relationship between bile 
acid and cholesterol secretion rates was curvilinear with the best fit 
to a hyperbolic function during bile acid pool depletion (r = 0.70) 
and during mainly CA secretion (r = 0.86). This type of function 
indicates a theoretical maximum for the cholesterol secretion rate, 
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which was calculated to be 2.8 umol . min"1 and 8.3 umol . min-"1 for 
bile acid pool depletion and CA secretion, respectively. Extrapola­
tion to zero bile acid secretion rate in these experiments gave a y-
intercept which was not statistically significantly different from 
zero, indicating that cholesterol is not secreted without bile acids. 
In the postcholestatic situation (II) a linear relationship 
between the bile acid secretion rate and the cholesterol secretion 
rate was obtained (r = 0.78), with a y-intercept not statistically 
significantly different from zero. The relatively narrow range of bile 
acid secretion rates in these postcholestatic patients may explain 
this difference in the type of function of the relationships between 
the bile acid and cholesterol secretion rates in the different experi­
mental situations. 
During CDCA infusion no statistically significant relationship 
between the bile acid and cholesterol secretion rates was found. 
Long-term administration of CDCA reduces the hepatic secretion of 
cholesterol (1, 38) and it has been suggested that the mechanism for 
this reduction might be decreased activity of HMG-CoA-reductase, the 
rate-limiting enzyme in cholesterol synthesis (12, 60). It cannot 
be determined whether such a mechanism is of any importance during 
short-term administration of CDCA and thus of any relevance for our 
results. 
In these studies of the diurnal variation of biliary lipid 
concentrations (I) statistically significant variations were found 
for cholesterol. The values during the day were lower than those in 
the night. No statistically significant variations could be shown 
for bile acids or lecithin. This finding is in line with the strong 
correlation between bile acid and lecithin secretion rates as compared 
with the weaker correlation between bile acid and cholesterol secre­
tion rates. 
During bile acid pool depletion and during biliary secretion of, 
mainly, cholic acid (IV) the correlation between the lecithin secre­
tion rate and the cholesterol secretion rate was strong, with the 
best fit to the parabolic function ( r = 0.72 and r = 0.94, respec­
tively) . The multiple correlation coefficient was not increased by 
addition of the bile acid secretion rate as another independent 
variable. In the depletion experiments the correlation between the 
19 
lecithin and cholesterol secretion rates was even stronger at bile 
acid secretion rates giving cholesterol-supersaturated bile (< 14.4 
umol . min (r = 0.80). During mainly CDCA secretion a statistically 
significant curvilinear relationship was found between the lecithin 
and cholesterol secretion rates, with the best fit to a parabolic 
function (r = 0.50). Addition of the bile acid secretion rate as a 
second independent variable to this relationship significantly raised 
the multiple correlation coefficient (R = 0.71). This means, in 
statistical terms, that the lecithin and bile acid secretion rates 
together accounted for 50 % of the total variation in the cholesterol 
secretion rate. At bile acid secretion rates (mainly CDCA) giving 
bile supersaturated with cholesterol (< 10.7 umol . min ) the 
correlation between the lecithin and cholesterol secretion rates was 
strong (r = 0.80). Within this range of bile acid secretion rates the 
correlation coefficient was not significantly changed by addition of 
the bile acid secretion rate as a second independent variable. 
The biological implications of these statistical relationships 
are by no means clear. However, they suggest that the secretory 
association between lecithin and cholesterol is strong and that it 
is stronger at low bile acid secretion rates and during CDCA secretion. 
To summarize, it may be assumed that the bile acids to a certain 
degree determine cholesterol secretion directly but also indirectly 
via the association between them and the lecithin secretion rate. 
In the postcholestatic situation (II) a curvilinear relationship 
with the best fit to a parabolic function was found between the 
lecithin and cholesterol secretion rates (r = 0.75). Addition of the 
bile acid secretion rate as a second independent variable significant­
ly raised the multiple correlation coefficient (R = 0.84). The basic 
secretion mechanisms in the postcholestatic situation thus seem to be 
unaffected by the disease. On the basis of the present results and 
calculations the role of lecithin for the biliary cholesterol secre­
tion cannot be assessed.However, they imply that lecithin may at least 
partly determine the mass of cholesterol which is secreted at lo\v 
bile acid secretion rates. This interpretation finds some support in 
the recent work by Robins and Armstrong,in which manipulation of 
the lecithin secretion rate only affected the rate of cholesterol 
secretion (59). 
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3. Bile acids and biliary cholesterol saturation 
The degree of cholesterol saturation (I, II, IV) can be expressed as 
the molar ratio §Ä^TTeclfKin• approximate limit for cholesterol 
solubility according to Admirand & Small (3 ) expressed in this way 
is 0.10. From a physicochemical point of view this limit is probably 
an overestimation of the cholesterol-holding capacity. According to 
Hegardt & Dam, Holzbach et al, and Mufson et al (30, 33, 45) the true 
limit is about 0.6 within the range of bile acid concentrations in 
human hepatic bile. However, if the transient metastable phase (32) 
is taken into account microcrystallization of cholesterol in human 
hepatic bile probably does not occur at molar ratios lower than 0.10. 
The relationship between the bile acid secretion rate and the 
ratio of the cholesterol secretion rate and the sum of the bile acid 
and lecithin secretion rates was studied. 
In all the experimental situations (I, II, IV) a statistically 
significant relationship was found between the bile acid secretion 
rate and the degree of cholesterol saturation. The type of function 
varied between the groups but in all cases the relationship was 
inverse, i.e. cholesterol saturation decreased with increasing bile 
acid secretion rate. 
During bile acid pool depletion (mixed biliary bile acids), 
during CA administration(biliary bile acids mainly consisting of CA) 
and during CDCA administration (biliary bile acids mainly consisting 
of CDCA), the cross-over point for the saturation limit according to 
Small was 14.4 + 1.6 (SEM), 15.6 + 0.5 (SEM) and 10.7 + 0.3 (SEM) 
umol bile acid . min \ respectively (Fig. 3). The cross-over point 
during mainly CDCA secretion was statistically significantly at a 
lower bile acid secretion rate than for the two other experimental 
situations (P< 0.01). 
In five gall stone patients, who were studied during depletion of 
the bile acid pool and subsequent duodenal administration of a mixture 
of cholic and chenodeoxycholic acid (I), the corresponding cholesterol 
saturation cross-over limit was 21.7 + 5 (SEM) umol . min 
The diurnal variation of biliary cholesterol saturation showed 
a similar pattern for nine out of ten patients (I). These nine 
patients had a higher cholesterol saturation degree during night-time 
as compared to day-time. Two patients produced bile supersaturated 
with cholesterol during the entire 24 h period. Seven patients 
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Fig. 3: Relationships between the bile acid secretion rate and 
cholesterol saturation during depletion of the bile acid pool (mixed 
bile acid secretion), during duodenal infusion of cholic acid (mainly 
cholic acid secretion) and during duodenal infusion of chenodeoxy-
cholic acid (mainly chenodeoxycholic acid secretion) after bile acid 
pool depletion. The dashed line indicates the approximate limit of 
cholesterol solubility according to Admirand and Small (3). 
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produced bile supersaturated with cholesterol most of the time (13 h) 
and in these patients the bile was unsaturated with cholesterol only 
for one period during the day. In five cholesterol gall stone patients 
with functioning gall bladder before the operation the degree of 
cholesterol saturation of hepatic bile showed a significant decrease 
postoperatively. This finding is in line with previous reports (69, 
72). In spite of the postoperative "normalization" of cholesterol 
saturation these gall stone patients produced supersaturated bile most 
of the time. For the time being we cannot determine the bile acid 
secretion rate at which the cholesterol saturation limit is crossed 
in normals. The present findings (IV) that the cholesterol saturation 
limit is crossed at a lower bile acid secretion rate when the bile 
acids consist mainly of CDCA as compared to CA or mixed bile acids 
are in line with the reports of effects of CDCA administration on 
biliary cholesterol saturation (1, 15, 38, 43, 55, 82, 83). It must be 
emphasized that the present experiments differ in one important 
respect from the studies described, viz the administration time period. 
Moreover, in the present experiments the bile acid pool was almost 
completely depleted when CDCA was administered. The mechanisms for 
cholesterol desaturation after CDCA administration in these short-
-term experiments may be quite different from the mechanisms for 
cholesterol desaturation during long-term administration of CDCA. 
When the cholesterol saturation line was crossed after two hours of 
CDCA administration, CDCA constituted 79 per cent of the bile acids. 
This is in good agreement with the findings of a saturation limit 
cross-over at approximately 70 per cent in 80 patients during CDCA 
treatment (18). 
General conclusion 
1. The two primary bile acids promote the same canalicular bile flow. 
2. Cholic acid secretion promotes a higher lecithin secretion rate 
than chenodeoxycholic acid does. 
3. Biliary cholesterol secretion in man is related to both the bile 
acid secretion rate and the lecithin secretion rate. 
4. Cholic acid secretion promotes a higher cholesterol secretion 
rate per umol of secreted bile acid than chenodeoxycholic acid does. 
5. The mass of cholesterol secretion may be dependent on the secretion 
rate of lecithin, especially during periods of low bile acid secre­
tion rates and during chenodeoxycholic acid secretion. 
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SUMMARY 
1. Bile flow in man is made up of a bile-acid-dependent and an 
independent canalicular flow and a bile-acid-independent ductular 
flow. During intact enterohepatic circulation of bile acids the 
canalicular flow constitutes 80 per cent, half of which is bile-
-acid-dependent, and the ductular flow constitutes 20 per cent. 
Cholic and chenodeoxycholic acid promoted the same canalicular 
bile flow in gall stone patients. 
Bile acids determine bile flow in the early phase after release 
of complete extrahepatic bile duct obstruction. 
2. Bile acids determine the biliary secretion of lecithin in gall 
stone patients during biliary bile acid secretion of mixed bile 
acids, mainly cholic acid and mainly chenodeoxycholic acid. More 
lecithin is secreted per umol of cholic acid than per umol of 
chenodeoxycholic acid after administration of cholic and chenodeoxy­
cholic acid, respectively, to gall stone patients with depleted 
bile acid pool. 
The role of bile acids as a determinant for the biliary cholesterol 
secretion rate is more pronounced when the biliary bile acids 
mainly consist of cholic acid than when they mainly consist of 
chenodeoxycholic acid. 
The role of bile acids as a determinant for biliary lecithin and 
cholesterol secretion is maintained in the postcholestatic phase. 
Biliary lecithin secretion influences the mass of biliary chole­
sterol secretion in gall stone patients during bile acid pool 
depeltion and when the biliary bile acids mainly consist of cholic 
acid and of chenodeoxycholic acid. This effect is maintained in the 
postcholestatic phase after release of extrahepatic biliary 
obstruction. 
Bile acid stimulation of the rate of incorporation of choline and 
methyl-methionine into human hepatic lecithins in vitro could not 
be demonstrated. 
3. The degree of cholesterol saturation was inversely related to the 
rate of biliary secretion of bile acids. The bile acid secretion 
rate at which the cholesterol saturation limit was reached was 
significantly lower when the biliary bile acids mainly consisted of 
chenodeoxycholic acid than when they mainly consisted of cholic 
acid in gall stone patients. 
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